- Role of ruxolitinib in the treatment of primary myelofibrosis2015 | Faculty of Medicine in Hradec Králové
- Experience with ruxolitinib in the treatment of myelofibrosis and polycythaemia vera at Czech haematological institutions2017 | Faculty of Medicine in Hradec Králové
- Impact of immunomodulatory drugs in treatment of primary myelofibrosis2015 | Faculty of Medicine in Hradec Králové
- Final report of University Hospital Hradec Kralove to the clinical trial protocol no. CINC424A2401Publication without faculty affiliation
- Idiopatic myelofibrosis complicated by portal hypertension treated with transjugular intrahepatic portosystemic shunt (TIPS)Publication without faculty affiliation
- Report of University Hospital Hradec Králové to the clinical trial protocol No: GS-US-352-0101Publication without faculty affiliation
- New approaches in the diagnosis and the treatment of idiopathic myelofibrosisPublication without faculty affiliation
- Allogenic transplantation of haematopoietic stem cells in idiopathic myelofibrosisPublication without faculty affiliation
- Decrease of myelofibrosis after therapy 2-CdA in patients with hairy cell leukemiaPublication without faculty affiliation
- Complete Regression of Bone Marrow Fibrosis Following Allogeneic Peripheral Blood Stem Cell Transplantation in a Patient with Idiopathic Myelofibrosis2004 | First Faculty of Medicine
- Successful treatment of anemia and trombocytopenia with Thalidomide and Prednison in idiopatic myelofibrosis2006 | Publication without faculty affiliation
- Complete Regression of Bone Marrow Fibrosis Following Allogeneic Peripheral Blood Stem Cell Transplantation in a Patient with Idiopathic Myelofibrosis2004 | Faculty of Medicine in Hradec Králové
- Histological diagnosis of Ph-negative myeloproliferative neoplasia. An overview2011 | Second Faculty of Medicine
- Diagnosis and treatment of BCR/ABL-negative myeloproliferative diseases - principles and rationale of CZEMP recommendations2011 | First Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Allogenic transplantation of haemoplastic progenitor cells in chronic myeloproliferations2006 | Publication without faculty affiliation
- Allogenic transplantation of haemoplastic progenitor cells in chronic myeloproliferations2006 | First Faculty of Medicine
- Extramedullary hematopoiesis with predominant renal involvement2007 | Central Library of Charles University, Faculty of Medicine in Pilsen
- Extramedullary hematopoiesis with predominant renal involvement2007 | First Faculty of Medicine, Faculty of Medicine in Pilsen
- Diagnosis and treatment of BCR/ABL-negative myeloproliferative diseases - principles and rationale of CZEMP recommendations2011 | Second Faculty of Medicine
- Guidelines of Czech working group for Ph- myeloproliferative disease (CZEMP) of Czech society of hematology for diagnosis and therapy of BCR/ABL negative myeloproliferation2012 | First Faculty of Medicine, Faculty of Medicine in Hradec Králové, Second Faculty of Medicine
- Summary of recommendations of the Czech Working Group Ph-negative myeloproliferative diseases (CZEMP) Czech Society of Hematology CLS JEP for diagnosis and treatment of BCR / ABL-negative myeloproliferative2012 | Second Faculty of Medicine
- Cerebral toxoplasmosis in a patient with chronic myeloid leukemia after allogenic unrelated transplantation of haematopoietic cells2006 | First Faculty of Medicine
- Analysis of risk factor : the rationale of the guildelines of the Czech Hematological Society for diagnosis and treatment of chronic myeloproliferative disorders with thrombocythemia2006 | First Faculty of Medicine
- PH negative myeloproliferative neoplasms in Czech haematological centres - MIND analysis2021 | Faculty of Medicine in Hradec Králové